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Abstract 
Background: MicroRNAs play an essential role in colorectal cancer development and progression. Aberrant  
miR-409-3p expression has been reported in several cancers. However, the clinical significance and functions of  
miR-409-3p in human CRC were not entirely clear.
Methods: miR-409-3p expression levels were determined in 45 pairs of primary CRC and their corresponding  
adjacent non-tumor tissues by qPCR. The effects of ectopic expression of miR-409-3p on CRC cells proliferation, 
wound healing, metastasis were investigated by CCK-8, transwell assay and peritoneal spreading nude mice model.
Results: Statistical analysis of clinical cases revealed that low miR-409-3p expression had inclinations towards lager 
tumor size and local invasion. Ectopic expression of miRNA mimics suggested that miR-409-3p could inhibits the 
abilities of proliferation, wound healing, metastasis and invasion in CRC cells. Notably, we found the NLK could be a 
potential target of miR-409-3p.
Conclusion: Our results suggest that miR-409-3p functions as a tumor suppressor by inhibiting the development 
and metastasis of CRC, suggesting that miR-409-3p is expected to become a new diagnostic marker and a new target 
of the treatment of CRC.
Keywords: miR-409-3p, CRC, NLK, Tumorigenesis
© 2015 Liu et al. This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://
creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided 
you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate 
if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/
zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Background
Colorectal carcinoma (CRC) is one of the prevalent can-
cer types, ranking the third of all cancer-related deaths 
worldwide. Its incidence increases with the change of 
life style and dietary structure [1], and the metastasis is 
the major cause of deaths for CRC patients [2]. Although 
many related genes have been identified in CRC [3], the 
complicated molecular mechanism of CRC development 
and progression has not been well understood.
MicroRNAs are non-coding small RNAs that regulate 
gene expression at the post-transcriptional level, and they 
are involved in many biological signaling pathways [4]. 
miRNAs can bind to sequences in 3′-UTR of their targets 
and induce mRNA degradation or translational repression 
[5]. Many studies have reported significant difference of 
microRNAs expression profiling between tumor cells and 
cells derived from normal tissues, indicating that microR-
NAs have played important roles in tumorigenesis [6, 7]. 
MicroRNA-409 dysregulation has been detected in many 
cancers, including gastric cancer [8, 9], prostate cancer 
[10] and bladder cancer [11]. However, the function of the 
miRNA in colon cancer is largely unknown. A recent study 
demonstrated that miR-409-3p could be used for early 
detection of CRC [12]. Therefore, we focused on miR-
409-3p to further investigate its association with CRC.
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In this study, we analyzed the down-regulation expres-
sion of miR-409-3p in CRC tissues compared with 
patient-matched normal tissues, and determined that the 
expression level of miR-409-3p was closely correlated with 
the clinicopathologic variables of CRC. Ectopic expres-
sion of miR-409-3p inhibits proliferation, invasion and 
metastasis of CRC cells, reduces the tumorigenic ability 
of CRC cells in nude mice. We also show that miR-409-3p 
may function as an tumor suppressor by directly targeting 
NLK. Thus, our results suggest that miR-409-3p is a poten-
tial diagnostic marker and therapeutic target of CRC.
Methods
Cell culture
Human colorectal cancer cell lines, SW480 and SW1116, 
were purchased from American Type Culture Collection 
(ATCC). SW480 and SW1116 were cultured in Leibovitz’ 
L-15 Medium (Corning Cellgro®, Manassas, VA, USA) 
with 10% fetal bovine serum (FBS) (Invitrogen, Carlsbad, 
CA, USA) and 2 mM l-glutamine. Cells were maintained 
at 37°C/5% CO2 in a humidified incubator.
RNA isolation and qRT‑PCR
Total RNA was extracted from cell lines and tissue sam-
ples using a mirVana™ miRNA Isolation Kit (Applied 
Biosystems, Foster City, CA, USA) according to the 
manufacturer’s instructions. Concentrations and purity 
of the RNA samples were measured by electrophoresis 
and spectrophotometric methods. The expression level of 
miR-409-3p in cell lines and tissue samples was assayed 
by qRT-PCR and calculated.
Transient transfection of miRNA mimics
miRNA-409-3p mimics and negative control mimics 
were purchased from GenePharma (Shanghai, China). 
Cells were seeded into cell culture plates  20  h before 
transfection to ensure 70% cell confluence at the moment 
of transfection. Transfection of miRNA mimics into CRC 
cells was carried out using Lipofectamine2000 (Invitro-
gen, Carlabad, CA, USA) according to the manufacturer’s 
procedure. The miRNA mimics worked at the final con-
centration of 100  nM. At 48  h post-transfection, qPCR 
and Western blot were performed.
Cell proliferation assay
Cell proliferation was assessed by WST (water-soluble 
tetrazolium salt) assay using the Cell Counting Kit-8 
(Dojindo, Kumamoto, Japan) and measured as described 
in the manufacturer’s instruction. At 24  h post-trans-
fection with mimics or control mimics, CRC cells were 
seeded onto 96-well plates (2 ×  103 cells/well), and cell 
proliferation was documented every 24 h for 4 days. The 
number of viable cells was assessed by measurement of 
the absorbance at 450 nm.
Wound healing assay
For scratch wound healing assay, cells were cultured in 
serum-free medium for 24 h and wounded with pipette 
tips. Fresh medium was replaced. The wound closing 
procedure was observed for 48 h, and photographs were 
taken every 24 h.
Colony formation assay
In plate colony formation assay, cells were resuspended in 
RPMI 1640 containing 10% FBS and layered onto 6-well 
plates (5 ×  102 cells/well). The cells were incubated for 
2 weeks and stained with crystal violet. Colonies contain-
ing 50 cells or more were counted.
Cell migration and invasion assay
Cell migration and invasion assay was performed using 
transwell chamber (8  μm, 24-well format; Corning, 
Lowell, MA, USA). In migration assay, Cells (1 × 105) in 
0.2  ml of serum-free medium were added to the upper 
chamber, and 0.6 ml of medium containing 10% FBS were 
added to the lower. Cells were then incubated for 24  h. 
For invasion assay, diluted Matrigel (BD Biosciences) 
was used to coat the insert chambers’ membrane. Cells 
were cultured for 48 h under the same conditions. Finally, 
cells that migrated or invaded into the lower chambers 
were fixed with methanol, stained with crystal violet and 
counted in six random fields.
In vivo metastasis peritoneal spreading assay
CRC cells were resuspended and injected intraperi-
toneally (2  ×  106 cells/mouse) into 4-week-old male 
BALB/C nude mice (Institute of Zoology, Chinese Acad-
emy of Sciences of Shanghai). Five mice were enrolled 
in each group. 8  weeks after intraperitoneal injection, 
mice were euthanized by cervical dislocation, and peri-
toneal spreading of tumor lesions was assessed by nec-
ropsy. All experiments were performed in accordance 
with the official recommendations of the Chinese Animal 
Committee.
Statistical analysis
The relationship between the miR-409-3p expression 
level and clinicopathologic parameters was analyzed by 
the Person χ2 test. The differences between groups were 
analyzed using Student t test. All statistical analyses were 
performed using the SPSS 13.0 software (SPSS Inc, Chi-
cago, IL, USA), and P < 0.05 was considered significant.
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Results
The expression of miR‑409‑3p is down‑regulated in CRC 
and correlated with tumor size, and local invasion
To explore the expression levels of miR-409-3p in CRC 
tissues and adjacent non-tumor tissues, qRT-PCR analy-
sis was performed. 45 CRC paired samples were included 
in this study. The results showed that the average 
expression level of miR-409-3p was significantly down-
regulated in tumor tissues compared to the adjacent non-
tumor tissues (Figure 1a, b). Furthermore, we elucidated 
the correlation between miR-409-3p expression and 
clinicopathologic factors. As shown in Table  1, we also 
evaluated the relationship between miR-409-3p expres-
sion levels and its clinicopathologic characteristics in 45 
CRC patients. Results showed that the low expression of 
miR-409-3p was significantly correlated with tumor size 
and local invasion (*P < 0.05). Whereas, miR-409-3p level 
was not associated with other clinicopathologic features, 
including age, sex (P > 0.05).
miR‑409‑3p inhibits CRC cells proliferation 
and clonogenicity of CRC cells in vitro
Considering that miR-409-3p is significantly down-reg-
ulated in CRC, it may function as a tumor suppressor. 
Therefore, we next determined whether overexpression 
of miR-409-3p in CRC cells could affect cell prolifera-
tion. miR-409-3p mimics or control mimics oligos were 
transfected into CRC cells respectively. We examined 
the effects of miR-409-3p on cell growth by WST cell-
growth assay. The results showed that cell growth was 
inhibited in cells transfected with miR-409-3p mimics 
compared with the cells transfected with control mim-
ics (Figure  2a, b). To further characterize the effect of 
miR-409-3p on cell proliferation, the colony forma-
tion assay was performed. The results showed that the 
number of colonies from CRC cells transfected with 
miR-409-3p mimics was significantly fewer than that 
from the control group (Figure  2c, d). The number of 
colonies from SW480miR-409-3p and SW1116miR-409-3p 
cells was fewer than that from the control groups 
(SW480NC mimics and SW1116NC mimics, *P  <  0.05, 
Figure 2e, f). These findings indicate that miR-409-3p inhib-
its the proliferation and colony forming ability of CRC cells.
miR‑409‑3p inhibits scratch wound healing ability of CRC 
cells
We detected whether miR-409-3p can change the move-
ment ability of CRC cells by scratch healing assay. The results 
Figure 1 miR-409-3p is downregulated in CRC tissues. a Relative expression of miR-409-3p in 45 CRC patients tumor tissues compared with 
adjacent non-tumor tissues. qRT-PCR results are shown as −CT values. b Expression levels of miR-409-3p in 45 CRC patients were analyzed by 
qRT-PCR. Data is shown as 2−Ct (*P < 0.05).
Table 1 Relationship between miR-409-3p expression lev-
els and clinicopathological variables in 62 CRC patients





miR‑409 expression P value
Low (n = 38) High (n = 24)
Age (years) 0.180
 <60 27 14 13
 ≥60 35 24 11
Gender 0.173
 Male 32 17 15
 Female 30 21 9
Tumor size (cm) 0.027*
 <5 33 16 17
 ≥5 29 22 7
Local invasion 0.011*
 T1, T2 13 4 9
 T3, T4 49 34 15
Lymph node 0.118
 N0 31 16 15
 N1–N3 31 22 9
Metastasis 0.702
 M0 53 33 20
 M1 9 5 4
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were shown in Figure  3a, miR-409-3p overexpression cell 
lines SW480miR-409-3p restoration slowly closed the scratch 
wounds compared with the control 48 h after scratching, in 
contrast to the control SW480NC mimics cells which were sig-
nificantly efficient in wound healing. The results in SW1116 
cells groups are consistent with above data (Figure 3b).
miR‑409‑3p inhibits migration and invasion of CRC cells 
in vitro
In order to further assess the influence of miR-409-3p 
on CRC cells, we further explored its effects on cell 
migration and invasion, a key ability of tumor progres-
sion and metastasis. The results showed that overex-
pression of miR-409-3p led to significantly inhibited 
migration and invasion of CRC cells. As shown in Fig-
ure  3, the number of migratory and invasive SW480 
cells transfected with miR-409-3p mimics was signifi-
cantly less than the control group (*P < 0.05. Figure 4a, 
b), and number of migratory and invasive SW1116 
cells transfected with miR-409-3p was significantly less 
compared to the control group (*P  <  0.05, **P  <  0.01. 
Figure 4c, d).
Figure 2 The effect of miR-409-3p on the proliferation of CRC cells. a Cell proliferation was measured by the WST assay. SW480 cells were trans-
fected with miR-409-3p mimics or NC mimics at a final concentration of 100 nM and, at 24 h post-transfection, the WST assay was performed every 
24 h for 4 days. Results aremeans of three independent experiments ± SD (**P < 0.01). b SW1116 cells were transfected with miR-409-3p mimics or 
NC mimics at a final concentration of 100 nM and, at 24 h post-transfection, the WST assay was performed every 24 h for 4 days. Results are means 
of three independent experiments ± SD. c The effect of miR-409-3p on cell proliferation was evaluated by the plate colony formation assay. SW480 
cells were transfected with miR-409-3p mimics or NC mimics then seeded onto 6-well plates. The number of colonies was counted on the 14th day 
after seeding. d SW1116 cells were transfected with miR-409-3p mimics or NC mimics then seeded onto 6-well plates. The number of colonies was 
counted on the 14th day after seeding. e, f Colonies containing 50 or more cells were counted. Results are means of three independent experi-
ments ± SD (*P < 0.05).
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miR‑409‑3p induces CRC cells apoptosis
To investigate the mechanism of miR-409-3p on CRC cell 
proliferation inhibitory effects, we performed apopto-
sis analysis by flow cytometry. The results indicated that 
apoptotic rate was significantly increased in miR-409-3p 
mimics transfected groups compared to the control 
groups both in SW480 and SW1116 cells (Figure 5). The 
results supported that miR-409-3p could be a potential 
therapeutic target.
miR‑409‑3p inhibits peritoneal spreading CRC cells  
in nude mice in vivo
Given that miR-409-3p inhibits metastasis of CRC cells in 
vitro, we next tested whether ectopic expression of miR-
409-3p could influence the tumor growth and metastasis 
of CRC cells in vivo. To confirm the contribution of miR-
409-3p in vivo, we carried out peritoneal spreading in 
mice models. CRC cells transfected with miR-409 mimics 
or control mimics were selected and intraperitoneally 
injected into nude mice, These mice were euthanized 
8 weeks after the injection, and the tumor lesions in the 
peritoneal cavity were counted. Strikingly, the peritoneal 
nodules were significantly inhibited in miR-409-3p mim-
ics transfected group compared with control group (Fig-
ure 6). Thus, these results indicate that miR-409-3p could 
suppress metastasis of CRC cells in vivo.
miR‑409‑3p targets the 3′‑UTR of NLK
To identify how miR-409-3p functions in CRC cells, com-
putational prediction of miR-409-3p targets was performed. 
We searched miR-409-3p’s putative targets using online 
search tools (e.g. TargetScan, Microrna.org and RNAhy-
brid) [13–17]. The genes predicted by all the used programs 
were considered candidate targets of miR-409-3p. Among 
all the hits, NLK caused our attention (Figure  7a, b). We 
then performed luciferase reporter assays to verify a direct 
Figure 3 miR-409-3p inhibits scratch wound healing ability of CRC cells. a Movement ability of SW480NC mimics and SW480miR-409-3p cell lines was 
detected by scratch wound healing assays. b Movement ability of SW1116NC mimics and SW1116miR-409-3p cell lines was detected by scratch wound 
healing assays. By wound distance analysis, the movement ability of CRC cells was inhibited by miR-409-3p.
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Figure 4 miR-409-3p inhibits migration and invasion of CRC cells. a Representative photographs of migratory or invasive SW480NC mimics and 
SW480miR-409-3p cells on the membrane (magnification, ×100). b Average number of migratory or invasive SW480NC mimics and SW480miR-409-3p 
cells. (*P < 0.05). c Representative photographs of migratory or invasive SW1116NC mimics and SW1116miR-409-3p cells on the membrane (magnifica-
tion, ×100). d Average number of migratory or invasive SW1116NC mimics and SW1116miR-409-3p cells (*P < 0.05, **P < 0.01). The data represent the 
mean ± SD of three independent experiments.
Figure 5 miR-409-3p induces CRC cells apoptosis. a Representative histograms depicting apoptosis of SW480 cells transfected with miR-409-3p 
mimics or control. b Representative histograms depicting apoptosis of SW1116 cells transfected with miR-409-3p mimics or control. c The percent-
age apoptotic cells of three independent experiments ± SD (**P < 0.01).
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interaction between miR-409-3p and the 3′UTR of NLK. 
Luciferase reporters were constructed containing either a 
wild-type NLK 3′UTR sequence containing the miR-409-3p 
binding site (NLK-3′UTRwt), or a mutated 3′UTR (NLK-
3′UTRmut) (Figure 7c). The relative luciferase activity of the 
NLK-3′UTRwt reporter was markedly suppressed by miR-
409-3p mimics compared with that of NLK-3′UTRmut in 
a miR-409-3p dependent manner (Figure  7d). This result 
strongly indicates that 3′UTR of NLK carries the direct 
binding seed of miR-409-3p.
Figure 6 miR-409-3p inhibits peritoneal spreading in nude mice. a, b Representative images of nude mice injected with indicated cells. c Quantifi-
cation of the peritoneal nodules is shown in the bar graph. The results are mean ± SD, *P < 0.05.
Figure 7 miR-409-3p targets the 3′-UTR of the oncogene NLK. a The putative binding sites of miR-409-3p in NLK 3′-UTR region were predicted. 
The matched seed sequences were indicated by vertical lines. b The minimum free energy (mfe) required for RNA hybridization was predicted by 
RNAhybrid software (mfe: −9.3 kcal/mol). c Schematic graph of the putative binding sites of miR-409-3p in the NLK 3′UTR and the mutation in 
miR-409-3p-binding sites. d miR-409-3p mimics down-regulated luciferase activities controlled by wild-type NLK 3′UTR (*P < 0.01), but did not affect 
luciferase activity controlled by mutant NLK 3′UTR. The results are means of three independent experiments ± SD.
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Discussion
In recent years, many studies have confirmed the key role 
of miRNAs in CRC. Although the signatures of miRNAs 
on CRC have been well characterized, the functions of 
dysregulated miRNAs in CRC progression and develop-
ment remains unclear. In pervious studies, dysregula-
tion of miR-409-3p has been reported in many cancers, 
including gastric cancer [8, 9], prostate cancer [10] and 
bladder cancer [11]. In these studies, the expression lev-
els of miR-409-3p was significantly lower in cancer tis-
sues compared with corresponding non-tumor tissues, 
and it inhibits proliferation, invasion and tumorigenesis 
in vitro or in vivo, suggesting that it may serve as a tumor 
suppressor. miR-409-3p has not yet been well explained 
in CRC.
In the present study, statistical analysis of clinical cases 
revealed that low miR-409-3p expression had inclinations 
towards lager tumor size and local invasion. The results 
suggested that the functions of miR-409-3p in CRC 
were worthy to study further. Ectopic expression of miR-
409-3p mimics suggested that miR-409-3p could inhibits 
the abilities of proliferation, wound healing, metastasis 
and invasion in CRC cells. The peritoneal spreading nude 
mice assay confirmed that miR-409-3p could inhibits 
the ability of metastasis in CRC cells in vivo, which is an 
important aspect of tumor development.
MiRNAs have been usually recognized as regulatory 
factors through decreasing translation of target mRNA or 
increasing degradation of target mRNA [18]. It has been 
reported that miR-409-3p targets PHF10, radixin and 
c-Met [8, 9, 11, 19] Here, we found that NLK could be a 
potential target of miR-409-3p since NLK would be the 
potential target in the CRC scenario.
NLK, an evolutionarily conserved serine/threonine 
protein kinase [20], is involved in many important bio-
logical processes and signaling pathways, such as Wnt/
β-catenin pathway. This pathway and its downstream 
components have a key role in cancer progression and 
development through many processes including tumor 
initiation, proliferation and metastasis [21]. The role of 
NLK in different tumors was incoherent. NLK was pre-
sumed to be a tumor suppressor gene in ovarian cancer, 
glioma and prostate cancer [22–24]. While in gallbladder 
cancer, hepatocellular carcinoma and laryngeal cancer, 
NLK functioned as oncogene [25–27]. In a recent study, 
the expression levels of NLK were significantly upregu-
lated in CRC tissues compared to which in matched 
non-tumor tissues, and the NLK expression was signifi-
cantly correlated with the clinicopathological features 
including the depth of tumor invasion [28]. This result 
is consistent with the expression profile of miR-409-3p 
in our study. A recent investigation on a large cohort 
of over 2,000 CRC patients indicated that NLK might 
promote the aggressiveness of CRC, which is consistent 
with the expression profile of miR-409-3p in the pre-
sent study. NLK was essential for CRC tumor initiation 
but not required for tumor progression in murine CRC 
model [29]. All these findings suggest that NLK plays an 
important role in CRC tumorigenesis, but the role in dif-
ferent CRC tumors might be somewhat different. It will 
be of interest to elaborate the exact role of NLK in human 
CRC progression under different conditions. As a nega-
tive regulator of NLK, miR-409-3p has a naturally poten-
tial value in personalized medicine. The combination of 
protein gene and miRNA has been emerged as a tool to 
predict the efficacy of treatment [30, 31].
The transcriptional regulation of miR-409-3p has been 
implicated in some diseases [32, 33]. The transportation 
of miR-409-3p was implicated in early CRC detection 
[12]. Therefore, the mechanism underlying the control 
of miR-409-3p level in colorectal cells is expected to be 
addressed in the future study.
Conclusion
In conclusion, our data showed that miR-409-3p was fre-
quently down-regulated in CRC. miR-409-3p functions 
as a tumor suppressor by inhibiting the development 
and metastasis of CRC, suggesting that miR-409-3p is 
expected to become a novel diagnostic marker and a new 
target of the treatment of CRC.
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